• 2022-05-22
    Last Updated
  • 200
    Pages

Companion Diagnostics Market - Forecast(2022 - 2030)

DESCRIPTION
TABLE OF CONTENT

According to Marketreports.info Companion Diagnostics Market report 2030, discusses various factors driving or restraining the Companion Diagnostics market, which will help the future market to grow with promising CAGR. The Companion Diagnostics Market Research Reports offers an extensive collection of reports on different markets covering crucial details. The Companion Diagnostics report studies the competitive environment of the Companion Diagnostics Market is based on company profiles and their efforts on increasing product value and production.

Companion Diagnostics Market research study involved the extensive usage of both primary and secondary data sources. The Companion Diagnostics research process involved the study of various factors affecting the industry, including market environment, competitive landscape, historical data, present trends in the Companion Diagnostics market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers, and challenges.

The final Companion Diagnostics report will add the analysis of the Impact of Covid-19 in this report Companion Diagnostics Market.

Adapting to the recent novel COVID-19 pandemic, the impact of the COVID-19 pandemic on the global Companion Diagnostics Market is included in the present Companion Diagnostics report. The influence of the novel coronavirus pandemic on the growth of the Companion Diagnostics Market is analyzed and depicted in the report.

Some of the companies competing in the Companion Diagnostics Market are 

Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Life Technologies, GE Healthcare, Agendia, Qiagen, Genomic Health, Myriad Genetics, Advanced Cell Diagnostics, Danaher, Applied Proteomics

Segment by Type
- Polymerase Chain Reaction (PCR)
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Next Generation Sequencing (NGS)

Segment by Application
- Hospitals
- Pharmaceutical Companies
- Laboratories
- Other

The Companion Diagnostics report scrutinizes different business approaches and frameworks that pave the way for success in businesses. The Companion Diagnostics report used expert techniques for analyzing the Companion Diagnostics Market; it also offers an examination of the global Companion Diagnostics market. To make the report more potent and easier to understand, it consists of infographics and diagrams. Furthermore, it has different policies and development plans which are presented in summary. It analyzes the technical barriers, other issues, and cost-effectiveness affecting the Companion Diagnostics market.

Global Companion Diagnostics Market Research Report 2022 carries in-depth case studies on the various countries which are involved in the Companion Diagnostics Market. The Companion Diagnostics report is segmented according to usage wherever applicable and the report offers all this information for all major countries and associations. It offers an analysis of the technical barriers, other issues, and cost-effectiveness affecting the Companion Diagnostics market. Important contents analyzed and discussed in the Companion Diagnostics report include market size, operation situation, and current & future development trends of the Companion Diagnostics market, market segments, business development, and consumption tendencies. Moreover, the report includes the list of major companies/competitors and their competition data that helps the user to determine their current position in the market and take corrective measures to maintain or increase their share holds.

What questions does the Companion Diagnostics Market report answer about the regional reach of the industry

The Companion Diagnostics report claims to split the regional scope of the Companion Diagnostics Market into North America, Europe, Asia-Pacific, South America & Middle East and Africa. Which among these regions has been touted to amass the largest market share over the anticipated duration

  • How do the sales figures look at present How does the sales scenario look for the future?
  • Considering the present Companion Diagnostics scenario, how much revenue will each region attain by the end of the forecast period
  • How much is the Companion Diagnostics market share that each of these regions has accumulated presently
  • How much is the Companion Diagnostics growth rate that each topography will depict over the predicted timeline

The scope of the Companion Diagnostics Report:

The report segments the global Companion Diagnostics Market based on application, type, service, technology, and region. Each Companion Diagnostics report chapter under this segmentation allows readers to grasp the nitty-gritty of the Companion Diagnostics market. A magnified look at the segment-based analysis is aimed at giving the readers a closer look at the opportunities and threats in the Companion Diagnostics market. It also addresses political scenarios that are expected to impact the market in both small and big ways. The Companion Diagnostics report on the global Companion Diagnostics Market examines changing regulatory scenarios to make accurate projections about potential investments. It also evaluates the risk for new entrants and the intensity of the competitive rivalry.

Reasons for buy this Report

  • Highlights key business priorities to assist Companion Diagnostics companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Companion Diagnostics market, thereby allowing players to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging Companion Diagnostics markets.
  • Scrutinize in-depth global Companion Diagnostics market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest to components, type, and end-users.
Chapter 1 Global Companion Diagnostics Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Companion Diagnostics Market
1.4 Restraints for Companion Diagnostics Market
1.5 Opportunities for Companion Diagnostics Market
1.6 Trends for Companion Diagnostics Market
1.7 COVID-19 Impact Assessment on Companion Diagnostics Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Companion Diagnostics Market Overview

2.1 Global Companion Diagnostics Market by Product Type
2.1.1 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Companion Diagnostics Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Companion Diagnostics Market by End User
2.2.1 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Companion Diagnostics Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Companion Diagnostics Market by Region
2.3.1 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Companion Diagnostics Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Companion Diagnostics Market Outlook (2013-2029)
2.4.1 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Companion Diagnostics Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Companion Diagnostics Market Y-o-Y Growth Rate by Region
2.8.2 Global Companion Diagnostics Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Companion Diagnostics Market Y-o-Y Growth Rate by End User
2.9 Global Companion Diagnostics Market Share Comparison (2013-2029)
2.9.1 Global Companion Diagnostics Market Share by Region
2.9.2 Global Companion Diagnostics Market Share by Product Type
2.9.3 Global Companion Diagnostics Market Share by End User

Chapter 3 North America Companion Diagnostics Market Overview

3.1 North America Companion Diagnostics Market by Product Type
3.1.1 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Companion Diagnostics Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Companion Diagnostics Market by End User
3.2.1 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Companion Diagnostics Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Companion Diagnostics Market by Region
3.3.1 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Companion Diagnostics Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Companion Diagnostics Market Outlook (2013-2029)
3.4.1 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Companion Diagnostics Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Companion Diagnostics Market Y-o-Y Growth Rate by Region
3.8.2 North America Companion Diagnostics Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Companion Diagnostics Market Y-o-Y Growth Rate by End User
3.9 North America Companion Diagnostics Market Share Comparison (2013-2029)
3.9.1 North America Companion Diagnostics Market Share by Region
3.9.2 North America Companion Diagnostics Market Share by Product Type
3.9.3 North America Companion Diagnostics Market Share by End User

Chapter 4 Europe Companion Diagnostics Market Overview

4.1 Europe Companion Diagnostics Market by Product Type
4.1.1 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Companion Diagnostics Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Companion Diagnostics Market by End User
4.2.1 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Companion Diagnostics Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Companion Diagnostics Market by Region
4.3.1 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Companion Diagnostics Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Companion Diagnostics Market Outlook (2013-2029)
4.4.1 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Companion Diagnostics Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Companion Diagnostics Market Y-o-Y Growth Rate by Region
4.8.2 Europe Companion Diagnostics Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Companion Diagnostics Market Y-o-Y Growth Rate by End User
4.9 Europe Companion Diagnostics Market Share Comparison (2013-2029)
4.9.1 Europe Companion Diagnostics Market Share by Region
4.9.2 Europe Companion Diagnostics Market Share by Product Type
4.9.3 Europe Companion Diagnostics Market Share by End User

Chapter 5 Asia Pacific Companion Diagnostics Market Overview

5.1 Asia Pacific Companion Diagnostics Market by Product Type
5.1.1 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Companion Diagnostics Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Companion Diagnostics Market by End User
5.2.1 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Companion Diagnostics Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Companion Diagnostics Market by Region
5.3.1 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Companion Diagnostics Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Companion Diagnostics Market Outlook (2013-2029)
5.4.1 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Companion Diagnostics Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Companion Diagnostics Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Companion Diagnostics Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Companion Diagnostics Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Companion Diagnostics Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Companion Diagnostics Market Share by Region
5.9.2 Asia Pacific Companion Diagnostics Market Share by Product Type
5.9.3 Asia Pacific Companion Diagnostics Market Share by End User

Chapter 6 South America Companion Diagnostics Market Overview

6.1 South America Companion Diagnostics Market by Product Type
6.1.1 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Companion Diagnostics Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Companion Diagnostics Market by End User
6.2.1 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Companion Diagnostics Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Companion Diagnostics Market by Region
6.3.1 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Companion Diagnostics Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Companion Diagnostics Market Outlook (2013-2029)
6.4.1 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Companion Diagnostics Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Companion Diagnostics Market Y-o-Y Growth Rate by Region
6.8.2 South America Companion Diagnostics Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Companion Diagnostics Market Y-o-Y Growth Rate by End User
6.9 South America Companion Diagnostics Market Share Comparison 2013-2029
6.9.1 South America Companion Diagnostics Market Share by Region
6.9.2 South America Companion Diagnostics Market Share by Product Type
6.9.3 South America Companion Diagnostics Market Share by End User

Chapter 7 MEA Companion Diagnostics Market Overview

7.1 MEA Companion Diagnostics Market by Product Type
7.1.1 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Companion Diagnostics Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Companion Diagnostics Market by End User
7.2.1 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Companion Diagnostics Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Companion Diagnostics Market by Region
7.3.1 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Companion Diagnostics Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Companion Diagnostics Market Outlook (2013-2029)
7.4.1 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Companion Diagnostics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Companion Diagnostics Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Companion Diagnostics Market Y-o-Y Growth Rate by Region
7.8.2 MEA Companion Diagnostics Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Companion Diagnostics Market Y-o-Y Growth Rate by End User
7.9 MEA Companion Diagnostics Market Share Comparison (2013-2029)
7.9.1 MEA Companion Diagnostics Market Share by Region
7.9.2 MEA Companion Diagnostics Market Share by Product Type
7.9.3 MEA Companion Diagnostics Market Share by End User

Chapter 8 Global Companion Diagnostics Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Licensing Options

One User
$3900
Enterprise User
$7800